Unknown

Dataset Information

0

Construction of a pneumolysin deficient mutant in streptococcus pneumoniae serotype 1 strain 519/43 and phenotypic characterisation.


ABSTRACT: Streptococcus pneumoniae capsular serotype 1 continues to pose a huge infectious disease burden in low- and middle-income countries, particularly in West Africa. However, studies on this important serotype have been hampered by the inability to genetically modify these strains. In this study we have genetically modified a serotype 1 strain (519/43), the first time that this has been achieved for this serotype, providing the methodology for a deeper understanding of its biology and pathogenicity. As proof of principle we constructed a defined pneumolysin mutant and showed that it lost its ability to lyse red blood cells. We also showed that when mice were infected intranasally with the mutant 519/43?ply there was no significant difference between the load of bacteria in lungs and blood when compared to the wild type 519/43. When mice were infected intraperitoneally there were significantly fewer bacteria recovered from blood for the mutant 519/43?ply strain, although all mice still displayed signs of disease. Our study demonstrates S. pneumoniae serotype 1 strains can be genetically manipulated using our methodology and demonstrate that the ability to cause pneumonia in mice is independent of active pneumolysin for the 519/43 serotype 1 strain.

SUBMITTER: Terra VS 

PROVIDER: S-EPMC7212698 | biostudies-literature | 2020 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

Construction of a pneumolysin deficient mutant in streptococcus pneumoniae serotype 1 strain 519/43 and phenotypic characterisation.

Terra Vanessa S VS   Plumptre Charles D CD   Wall Emma C EC   Brown Jeremy S JS   Wren Brendan W BW  

Microbial pathogenesis 20200126


Streptococcus pneumoniae capsular serotype 1 continues to pose a huge infectious disease burden in low- and middle-income countries, particularly in West Africa. However, studies on this important serotype have been hampered by the inability to genetically modify these strains. In this study we have genetically modified a serotype 1 strain (519/43), the first time that this has been achieved for this serotype, providing the methodology for a deeper understanding of its biology and pathogenicity.  ...[more]

Similar Datasets

| S-EPMC6729139 | biostudies-literature
| S-EPMC4668377 | biostudies-literature
2017-09-01 | GSE52890 | GEO
| S-EPMC9418233 | biostudies-literature
| S-EPMC4288861 | biostudies-literature
| S-EPMC10497322 | biostudies-literature
| S-EPMC10004606 | biostudies-literature
| S-EPMC165367 | biostudies-literature
| S-EPMC2949764 | biostudies-literature
| S-EPMC5479890 | biostudies-literature